Logo

Getting In On the Google Money

Oct 02, 2009

Google Ventures, formed back in March, has made its first investment into a biotech company, according to Fierce Biotech. The company invested about $13 million into antibody start-up Adimabm, which uses computational approaches to develop its antibody library. Google Venture plans to invest $100 million in biotech in the coming year. "Google Ventures has a pretty broad mandate," managing partner William Maris says to Dow Jones. "We're looking for [companies] that have potential to make a big impact."

Breaking News
The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.